BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6453416)

  • 21. Abnormal glucose tolerance and arginine tolerance tests in Huntington's disease.
    Podolsky S; Leopold NA
    Gerontology; 1977; 23(1):55-63. PubMed ID: 136379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone and prolactin secretion in Huntington's disease.
    Levy CL; Carlson HE; Sowers JR; Goodlett RE; Tourtellotte WW; Hershman JM
    Life Sci; 1979 Feb; 24(8):743-9. PubMed ID: 155768
    [No Abstract]   [Full Text] [Related]  

  • 23. Characterization of brain dopaminergic receptors in Huntington's disease.
    Reisine TD; Fields JZ; Bird ED; Spokes E; Yamamura HI
    Commun Psychopharmacol; 1978; 2(2):79-84. PubMed ID: 149628
    [No Abstract]   [Full Text] [Related]  

  • 24. Plasma growth hormone and prolactin response to dopaminergic GABAmimetic and cholinergic stimulation in Huntington's disease.
    Durso R; Tamminga CA; Denaro A; Ruggeri S; Chase TN
    Neurology; 1983 Sep; 33(9):1229-32. PubMed ID: 6225034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uptake of 5-hydroxytryptamine by blood platelets in Huntington's chorea and Alzheimer type of presenile dementia.
    Tukiainen E; Wikström J; Kilpeläinen H
    Med Biol; 1981 Apr; 59(2):116-20. PubMed ID: 6458746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison between various stimulation tests used for the study of somatotropic function in children].
    Donnadieu M; Combourieu M; Schimpff RM
    Pathol Biol (Paris); 1971 Mar; 19(5):293-301. PubMed ID: 4929992
    [No Abstract]   [Full Text] [Related]  

  • 27. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Growth hormone secretion in relation to changes in thyrotropic hormone after thyroliberin in patients with acromegaly and dopaminergic stimulation (author's transl)].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1982 Apr; 121(16):489-93. PubMed ID: 6807547
    [No Abstract]   [Full Text] [Related]  

  • 29. [Lipid metabolism disorders in parkinsonism and Huntington's chorea].
    Samorukov AE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(3):348-53. PubMed ID: 6446826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical studies in Huntington's chorea. 3. Aminoacids in serum and urine.
    Bruyn GW
    Psychiatr Neurol Neurochir; 1966; 69(2):139-42. PubMed ID: 4225277
    [No Abstract]   [Full Text] [Related]  

  • 31. Biochemical studies in Huntington's chorea. II. Composition of blood lipids.
    Hooghwinkel GJ; Borri PF; Bruyn GW
    Acta Neurol Scand; 1966; 42(2):213-20. PubMed ID: 4222877
    [No Abstract]   [Full Text] [Related]  

  • 32. [Significance of blood levels of prolactin and somatotropin as indices of pharmacological effects on the central nervous system].
    Barreca T; Gallamini A; Murialdo G; Nizzo MC; Polleri A
    Clin Ter; 1978 Jul; 86(2):147-59. PubMed ID: 743856
    [No Abstract]   [Full Text] [Related]  

  • 33. [Laboratory findings in 2 cases of Huntington's chorea].
    Marinać M; Purkov M
    Med Pregl; 1976; 29(1-2):39-41. PubMed ID: 130535
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of dopaminergic block on secretion of the growth hormone (author's transl)].
    Hainer V; Krejcík L; Urbánek J; Malec J
    Cas Lek Cesk; 1978 May; 117(19):590-2. PubMed ID: 679233
    [No Abstract]   [Full Text] [Related]  

  • 35. Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models.
    Martínez-Mir MI; Pollard H; Moreau J; Traiffort E; Ruat M; Schwartz JC; Palacios JM
    Synapse; 1993 Nov; 15(3):209-20. PubMed ID: 7904088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Eugenic counseling in Huntington's chorea].
    Ronzoni Bernardi MG
    Minerva Med; 1972 Dec; 63(86):4718-20. PubMed ID: 4264633
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical studies on the abnormality of glucose tolerance in acute stage of cerebrovascular diseases (author's transl)].
    Maruyama T
    Fukuoka Igaku Zasshi; 1978 Jun; 69(6):251-67. PubMed ID: 689584
    [No Abstract]   [Full Text] [Related]  

  • 38. [Response of growth hormone (GH) to glucagon-propranolol stimulation in diabetic subjects (author's transl)].
    Tébar J; Madrid J; Serrano S; Soriano J; Cayuela E; Ascaso J
    Med Clin (Barc); 1981 Apr; 76(8):361-4. PubMed ID: 7253755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroendocrinologic findings in patients with untreated Huntington's chorea.
    Caraceni TA; Parati EA; Giovannini PM; Grassi MP; Scigliano G; Carella F; Müller EE
    Arch Neurol; 1984 May; 41(5):516-20. PubMed ID: 6232913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Model of choreic movement in monkey--contribution for understanding the mechanism of chorea in Huntington's disease].
    Kanazawa I
    Jikken Dobutsu; 1990 Apr; 39(2):168-72. PubMed ID: 2141819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.